CAPLIPOINTPharmaceuticals
Caplin Point Laboratories Ltd — PE Ratio & Valuation Analysis
₹1558.40
-3.75%
Current P/E24.62xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E28.4x13.4% below avg
✅
22.5% Discount to Industry
CAPLIPOINT P/E 24.62x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹70.25 | ₹1838 | 26.2x |
| 2024 | ₹59.90 | ₹2501 | 41.7x |
| 2023 | ₹49.18 | ₹1356 | 27.6x |
| 2022 | ₹39.26 | ₹713 | 18.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Caplin Point Laboratories Ltd Valuation
Caplin Point Laboratories Ltd (CAPLIPOINT) currently trades at 24.62x earnings. The Pharmaceuticals sector average PE is 31.77x. CAPLIPOINT is trading at a discount to peers — may indicate relative value. Historically, CAPLIPOINT has traded at an average PE of 28.4x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
22.66%
Dividend Yield
0.31%
More on Caplin Point Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.